Cosequin

Verify with FDA CVM →

235 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
235
Total Reports
35
Deaths Reported
1490.0%
Death Rate

Active Ingredients

Cosequin

Administration Routes

OralUnknownSubcutaneous

Species Affected

Dog 184
Cat 51

Most Affected Breeds

Domestic Shorthair 38
Retriever - Labrador 37
Shepherd Dog - German 16
Retriever - Golden 15
Boxer (German Boxer) 9
Shepherd Dog - Australian 8
Crossbred Canine/dog 7
Terrier - Yorkshire 5
Terrier - Bull - American Pit 5
Collie - Border 5

Most Reported Reactions

Death by euthanasia 25
Lethargy (see also Central nervous system depression in Neurological) 24
Vomiting 23
Seizure NOS 21
Ataxia 20
Diarrhoea 18
Panting 17
Polydipsia 17
Lack of efficacy - NOS 15
Elevated alanine aminotransferase (ALT) 15
Weight loss 13
Not eating 13

Outcome Breakdown

Ongoing
134 (57.0%)
Recovered/Normal
37 (15.7%)
Outcome Unknown
29 (12.3%)
Euthanized
26 (11.1%)
Died
9 (3.8%)

Data Summary

Metric Value
Total adverse event reports 235
Reports involving death 35
Case-fatality rate (reported events) 1490.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cosequin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 235 adverse event reports referencing Cosequin, including 35 reports in which the animal died — a 1490.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cosequin. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cosequin reports are Dog (184 reports), Cat (51 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (38), Retriever - Labrador (37), Shepherd Dog - German (16) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cosequin are Death by euthanasia (25), Lethargy (see also Central nervous system depression in Neurological) (24), Vomiting (23), Seizure NOS (21). Of the 235 reports with a coded outcome, Ongoing is the leading category at 57.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cosequin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial